Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

PetVivo Holdings, Inc.

PETV · OTC · CIK 0001512922 · Healthcare · Medical Devices

INSIDER SIGNAL

45.5 / 100

1 buyers · 6 purchase transaction lines · $140.1K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeLow
RoleModerate
RecencyModerate
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+7.0 / 35
Purchase size+8.9 / 25
Role+14.0 / 20
Recency+5.7 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 1 insider(s), not 4+
  • ⚠ Purchase size is modest relative to the model scale
  • ⚠ Role scores low · most senior buyer: TenPercentOwner (CEO, chair and 10% owners score lowest)

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
A.L. Sarroff Fund, LLCTenPercentOwner
●○●●●●●
LOWENTHAL GARRY NChief Financial Officer
○○○○
Lai JohnChief Executive Officer
○○○○
Rudelius Robert JamesDirector
○
● Purchase▼ Sale○ Other

—

Purchase breadth & concentration

QUALIFYING BUYERS1
PURCHASE CONCENTRATION100%Largest buyer: A.L. Sarroff Fund, LLC · $140.1K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-05-22–2026-05-22

Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

45.5 / 100

Latest recorded score

↓ -0.2 ptsversus the previous recorded snapshot
  1. 46.1
  2. 45.9
  3. 45.9
  4. 45.7
  5. 45.5

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

41Purchases
0Sales
29Other Form 4 lines
30SEC filings · 365 days
BUYING6 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER11 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+11.5%
3M
-0.3%
6M
+3.4%
12M
-41.7%

Volatility & liquidity

Volatility
80.8%
Beta
—
Avg daily value
USD 7,681

Valuation

Market cap
USD 28.5M
P/E
—

Fundamentals

Profit margin
-917.4%
ROE
-476.2%
Industry
Medical Devices

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance; volume from price cache (yfinance) · From SEC filings: Market cap, Profit margin, ROE · Fiscal year ended: 2026-03-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-06-29 · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
20,106
Previous report
20,759
Avg daily volume
12,290
Days to cover
1.6

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-14A.L. Sarroff Fund, LLCPurchase (P)Common Stock24,888USD 0.69USD 17,173SEC filing ↗
2026-09-10A.L. Sarroff Fund, LLCPurchase (P)Common Stock10,974USD 0.68USD 7,462SEC filing ↗
2026-09-09A.L. Sarroff Fund, LLCPurchase (P)Common Stock22,160USD 0.68USD 15,069SEC filing ↗
2026-08-27A.L. Sarroff Fund, LLCPurchase (P)Common Stock580USD 0.69USD 400SEC filing ↗
2026-06-09A.L. Sarroff Fund, LLCPurchase (P)Common Stock187,500USD —USD —SEC filing ↗
2026-05-22A.L. Sarroff Fund, LLCPurchase (P)Common Stock250,000USD 0.40USD 100,000SEC filing ↗
2026-03-23A.L. Sarroff Fund, LLCPurchase (P)Common Stock24,033USD 0.68USD 16,412SEC filing ↗
2026-03-13A.L. Sarroff Fund, LLCPurchase (P)Common Stock1,250,000USD —USD —SEC filing ↗
2025-12-26A.L. Sarroff Fund, LLCPurchase (P)Common Stock2,400USD 1.16USD 2,790SEC filing ↗
2025-12-24A.L. Sarroff Fund, LLCPurchase (P)Common Stock14,632USD 1.09USD 15,934SEC filing ↗
2025-12-16A.L. Sarroff Fund, LLCPurchase (P)Common Stock7,700USD 1.15USD 8,855SEC filing ↗
2025-12-12A.L. Sarroff Fund, LLCPurchase (P)Common Stock1,100USD 1.14USD 1,254SEC filing ↗
2025-12-11A.L. Sarroff Fund, LLCPurchase (P)Common Stock10,000USD 1.17USD 11,700SEC filing ↗
2025-12-10A.L. Sarroff Fund, LLCPurchase (P)Common Stock6,700USD 1.14USD 7,638SEC filing ↗
2025-12-09A.L. Sarroff Fund, LLCPurchase (P)Common Stock5,100USD 1.11USD 5,661SEC filing ↗

Form 4 evidence

70 transaction lines in the latest 365-day window; 410 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-18Rudelius Robert JamesAward / grant (A)Common Stock3,497USD 0.73USD 2,563SEC filing ↗
2026-09-14A.L. Sarroff Fund, LLCPurchase (P)Common Stock24,888USD 0.69USD 17,173SEC filing ↗
2026-09-10A.L. Sarroff Fund, LLCPurchase (P)Common Stock10,974USD 0.68USD 7,462SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-18Rudelius Robert JamesAward / grant (A)Common Stock3,497USD 0.73USD 2,563SEC filing ↗
2026-09-14A.L. Sarroff Fund, LLCPurchase (P)Common Stock24,888USD 0.69USD 17,173SEC filing ↗
2026-09-10A.L. Sarroff Fund, LLCPurchase (P)Common Stock10,974USD 0.68USD 7,462SEC filing ↗
2026-09-09A.L. Sarroff Fund, LLCPurchase (P)Common Stock22,160USD 0.68USD 15,069SEC filing ↗
2026-09-09Lai JohnAward / grant (A)Common Stock31,250USD 0.80USD 25,000SEC filing ↗
2026-09-09Lai JohnAward / grant (A)Common Stock31,250USD 0.78USD 24,375SEC filing ↗
2026-09-08LOWENTHAL GARRY NAward / grant (A)Common Stock31,250USD 0.80USD 25,000SEC filing ↗
2026-09-08LOWENTHAL GARRY NAward / grant (A)Common Stock31,250USD 0.80USD 25,000SEC filing ↗
2026-08-27A.L. Sarroff Fund, LLCPurchase (P)Common Stock580USD 0.69USD 400SEC filing ↗
2026-07-21Lai JohnAward / grant (A)Common Stock75,000USD 0.77USD 57,750SEC filing ↗
2026-07-21LOWENTHAL GARRY NAward / grant (A)Common Stock75,000USD 0.77USD 57,750SEC filing ↗
2026-06-09A.L. Sarroff Fund, LLCPurchase (P)Common Stock187,500USD —USD —SEC filing ↗
2026-05-28A.L. Sarroff Fund, LLCGift (G)Common Stock200,000USD 0.00USD 0SEC filing ↗
2026-05-22A.L. Sarroff Fund, LLCPurchase (P)Common Stock250,000USD 0.40USD 100,000SEC filing ↗
2026-05-15Lai JohnAward / grant (A)Common Stock66,421USD 0.72USD 47,823SEC filing ↗
2026-05-15LOWENTHAL GARRY NAward / grant (A)Common Stock66,421USD 0.72USD 47,823SEC filing ↗
2026-04-15Rudelius Robert JamesAward / grant (A)Common Stock50,000USD 0.40USD 20,000SEC filing ↗
2026-03-23A.L. Sarroff Fund, LLCPurchase (P)Common Stock24,033USD 0.68USD 16,412SEC filing ↗
2026-03-13A.L. Sarroff Fund, LLCPurchase (P)Common Stock1,250,000USD —USD —SEC filing ↗
2026-03-09Rudelius Robert JamesAward / grant (A)Common Stock35,000USD 0.74USD 25,900SEC filing ↗
2026-03-09Ruben Joshua DavidAward / grant (A)Common Stock7,500USD 0.74USD 5,550SEC filing ↗
2026-03-09Levitan Diane MAward / grant (A)Common Stock15,000USD 0.74USD 11,100SEC filing ↗
2026-03-09Jasper Joseph WilliamAward / grant (A)Common Stock35,000USD 0.74USD 25,900SEC filing ↗
2026-03-09Costantino Robert JAward / grant (A)Common Stock35,000USD 0.74USD 25,900SEC filing ↗
2026-03-09Lai JohnAward / grant (A)Common Stock72,282USD 0.69USD 49,875SEC filing ↗
2026-03-09LOWENTHAL GARRY NAward / grant (A)Common Stock71,993USD 0.69USD 49,675SEC filing ↗
2026-01-02Ruben Joshua DavidAward / grant (A)Common Stock46,332USD 0.74USD 34,286SEC filing ↗
2025-12-31A.L. Sarroff Fund, LLCGift (G)Common Stock60,000USD 0.00USD 0SEC filing ↗
2025-12-26A.L. Sarroff Fund, LLCPurchase (P)Common Stock2,400USD 1.16USD 2,790SEC filing ↗
2025-12-24A.L. Sarroff Fund, LLCPurchase (P)Common Stock14,632USD 1.09USD 15,934SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPETV
CIK0001512922
SectorHealthcare
IndustryMedical Devices Yahoo Finance
SEC SIC3841 Surgical & Medical Instruments & Apparatus
ExchangeOTC

Data coverage

Local Form 4 history410 transaction lines from 2020-01-31 to 2026-09-18
270 P purchase lines · 5 S sale lines · 135 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.